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ABSTRACT
Flaviviruses, such as Zika virus, yellow fever virus, dengue virus, andWest Nile virus (WNV), are a serious concern for human
health. Flaviviruses produce an abundant noncoding subgenomic flavivirus RNA (sfRNA) in infected cells. sfRNA results from
stalling of the host 5=-3= exoribonuclease XRN1/Pacman on conserved RNA structures in the 3= untranslated region (UTR) of the
viral genomic RNA. sfRNA production is conserved in insect-specific, mosquito-borne, and tick-borne flaviviruses and flavivi-
ruses with no known vector, suggesting a pivotal role for sfRNA in the flavivirus life cycle. Here, we investigated the function of
sfRNA duringWNV infection of Culex pipiensmosquitoes and evaluated its role in determining vector competence. An sfRNA1-
deficientWNVwas generated that displayed growth kinetics similar to those of wild-typeWNV in both RNA interference
(RNAi)-competent and -compromised mosquito cell lines. Small-RNA deep sequencing ofWNV-infected mosquitoes indicated
an active small interfering RNA (siRNA)-based antiviral response for both the wild-type and sfRNA1-deficient viruses. Addition-
ally, we provide the first evidence that sfRNA is an RNAi substrate in vivo. Two reproducible small-RNA hot spots within the 3=
UTR/sfRNA of the wild-type virus mapped to RNA stem-loops SL-III and 3= SL, which stick out of the three-dimensional (3D)
sfRNA structure model. Importantly, we demonstrate that sfRNA-deficientWNV displays significantly decreased infection and
transmission rates in vivowhen administered via the blood meal. Finally, we show that transmission and infection rates are not
affected by sfRNA after intrathoracic injection, thereby identifying sfRNA as a key driver to overcome the mosquito midgut in-
fection barrier. This is the first report to describe a key biological function of sfRNA for flavivirus infection of the arthropod vec-
tor, providing an explanation for the strict conservation of sfRNA production.
IMPORTANCE
Understanding the flavivirus transmission cycle is important to identify novel targets to interfere with disease and to aid devel-
opment of virus control strategies. Flaviviruses produce an abundant noncoding viral RNA called sfRNA in both arthropod and
mammalian cells. To evaluate the role of sfRNA in flavivirus transmission, we infected mosquitoes with the flavivirusWest Nile
virus and an sfRNA-deficient mutantWest Nile virus. We demonstrate that sfRNA determines the infection and transmission
rates of West Nile virus in Culex pipiensmosquitoes. Comparison of infection via the blood meal versus intrathoracic injection,
which bypasses the midgut, revealed that sfRNA is important to overcome the mosquito midgut barrier. We also show that
sfRNA is processed by the antiviral RNA interference machinery in mosquitoes. This is the first report to describe a pivotal bio-
logical function of sfRNA in arthropods. The results explain why sfRNA production is evolutionarily conserved.
Viruses from the genus Flavivirus (family Flaviviridae), such asthe highly pathogenic dengue virus (DENV) (1), the emerging
Zika virus (2), and West Nile virus (WNV) (3, 4), are important
threats to human health and are collectively responsible for mil-
lions of annual reported cases of infection (5). Flaviviruses are
positive-sense single-stranded RNA (ssRNA) viruses that can in-
fectmany different hosts, including insects, ticks, birds, andmam-
mals (6). They can be further divided based on their vector species
into mosquito-borne flaviviruses (MBFs), tick-borne flaviviruses
(TBFs), and insect-specific flaviviruses (ISFs) andflaviviruseswith
no known vector (NKVFs). The epidemic potential of flaviviruses
was clearly demonstrated when WNV was first detected in New
York City in 1999, reaching the West Coast of the United States
only 4 years later, causing the largest outbreak of WNV-induced
neuroinvasive disease to date (7). In southern Europe, lineage I
WNV outbreaks were reported as early as the 1960s (8), but more
recently, a novel pathogenic lineage IIWNV isolate was identified
(4, 9, 10). In 2010, in Greece, an exceptionally severe outbreak of
this lineage II WNV strain resulted in 197 patients with neuroin-
vasive disease and 33 deaths (4). Understanding the determinants
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of transmission of these flaviviruses is important to evaluate their
epidemic potential and is the first step in designing novel ways to
break the flavivirus transmission cycle.
The overall capacity of a mosquito to become orally infected
after an infectious bloodmeal and to transmit the virus to the next
vertebrate host is expressed as the vector competence (11). For a
successful infection of the mosquito vector, arboviruses have to
overcome the midgut infection and escape barriers, as well as the
salivary gland barriers (12). After ingestion of a viremic blood
meal, the midgut epithelial cells have to become infected. These
cells have a strong RNA interference (RNAi) response that re-
stricts virus infection and acts as a bottleneck on virus population
diversity (13, 14). Next, the virus has to replicate in the midgut
cells, produce progeny virus, and escape from the midgut cells
through the basal lamina into the hemolymph. Subsequently, the
virus disseminates to other organs and ultimately infects the sali-
vary glands. After sufficiently high virus titers in the saliva have
been reached, viruses can be transmitted to a new vertebrate host
via a bite by the infected mosquito.
Vector competence is influenced by viral, environmental (e.g.,
temperature and the microbiome), and vector-related factors, in-
cluding vector genetics and antiviral responses (11). In arthro-
pods, antiviral responses are predominantly mediated by RNAi
(13, 15), and also byToll, IMD, and JAK/STAT signaling pathways
and apoptosis (16, 17). Three distinct insect small-RNA pathways
can be discriminated: the 21-nucleotide (nt) small interfering
RNA (siRNA) response, the 21- to 22-nt microRNA (miRNA)
pathway, and the 25- to 30-nt PIWI-interacting RNA (piRNA)
response (18–20). In Culexmosquitoes—the predominant group
of WNV vectors—virus-specific siRNAs are highly abundant,
whereas viral piRNAs (vpiRNAs) appear to be absent (14, 21). For
flaviviruses, three putative viral suppressors of RNAi (VSRs) have
been identified in vitro: the NS4B andNS3 proteins of DENV type
2 (DENV-2) and the noncoding subgenomic flavivirus RNA
(sfRNA) for WNV (22–24).
During viral replication in both vertebrate and invertebrate
host cells, flaviviruses produce a highly abundant noncoding
sfRNA approximately 0.5 kb in size. sfRNA is produced via a
unique mechanism involving degradation of the viral genomic
RNA (vgRNA) by the host 5=¡3= exoribonuclease XRN1/Pacman
(25). XRN1 stalls at stem-loop (SL) and dumbbell (DB) RNA
structures within the flaviviral 3= untranslated region (UTR), re-
sulting in the accumulation of sfRNA (26–29). The stalling of
XRN1 occurs due to steric hindrance caused by interactions of
pseudoknots (PK) and other tertiary RNA structures (30). During
WNV infection, three species of sfRNA, named sfRNA1, -2, and
-3, are produced by stalling of XRN1 on SL-II, SL-IV, and DB-1
(26, 29). The formation of sfRNA is important for replication in
insect cells and several types of vertebrate cells, since sfRNA mu-
tants that produce only sfRNA3 have attenuated replication rates,
even in Dicer-2-deficient C6/36 cells (25, 28, 29, 31). In mamma-
lian cells, sfRNA is essential for flavivirus-induced cytopathicity
and pathogenicity (25). Importantly, sfRNA acts as an antagonist
of both interferon- and retinoic acid-inducible gene-I-like recep-
tor-dependent innate immune responses (31, 32). Accordingly,
WNV mutants deficient in sfRNA production are attenuated in
mice (25, 29).
Despite the clear functions of sfRNA in flavivirus pathogenesis
in vertebrates, the role of sfRNA in the arthropod vector is poorly
understood. sfRNA production is conserved for all MBFs and
TBFs, and although recent RNA structure analysis of ISF 3= UTRs
failed to identify XRN1-resistant structures (33, 34), it was previ-
ously reported that ISFs and NKVFs have conserved SL structures
with putative pseudoknot structures in their 3= UTRs (35). In-
deed, sfRNA production has been experimentally shown for sev-
eral NKVFs and the ISF cell-fusing agent virus (36). The conser-
vation of sfRNA production byMBFs, TBFs, and ISFs emphasizes
the putative importance of sfRNA production in arthropods (35).
So far, it has been demonstrated that sfRNA acts as a suppressor of
miRNA- and siRNA-mediated RNAi in vitro in both mammalian
and arthropod cells (23, 37). The highly abundant sfRNA most
likely acts as a decoy substrate forDicer to prevent it from cleaving
other double-strandedRNA (dsRNA)molecules. Recently, sfRNA
has been demonstrated to mildly suppress the RNAi pathway in
vivo, but the biological significance of this suppression requires
more detailed studies (38). Based on the high abundance of sfRNA
in infected arthropod cells and the conservation of sfRNA inmost,
if not all, flavivirus genomes known to date (35), including those
restricted to replication in arthropods, we hypothesize that sfRNA
is a crucial factor for flavivirus transmission by the arthropod
vector.
In this study, the importance of sfRNA for dissemination and
transmission of WNV by Culex pipiens mosquitoes was investi-
gated. By using a lineage II WNV infectious clone deficient in
sfRNA formation, we investigated replication kinetics inmamma-
lian cells and both RNAi-competent and -deficient mosquito cell
lines. The putative role of sfRNA in modulating the RNAi re-
sponse in vivo was determined by a deep-sequencing approach
using viral small RNAs (vsRNAs). Notably, the importance of
sfRNA in WNV infection and transmission by Culex mosquitoes
was studied in vivo, and the role of the midgut epithelium was
assessed by comparison of infections via the blood meal and via
intrathoracic injections. The outcomes of this research highlight
the importance of sfRNA for flavivirus transmission by mosqui-
toes and provide a biological explanation as to why sfRNA pro-
duction is strictly conserved in the genus Flavivirus.
MATERIALS AND METHODS
Cell culture. Aedes albopictus U4.4 and C6/36 (ATCC CRL-1660) mos-
quito cells were cultured in Leibovitz L-15 medium (Gibco) supple-
mented with 10% fetal bovine serum (FBS) (Gibco), 2% tryptose phos-
phate broth (Gibco), and 1% nonessential amino acids (Gibco). Culex
tarsalis Cx.t cells (39) (CDC, Fort Collins, CO) were cultured in Schne-
ider’s medium (Gibco) supplemented with 10% FBS. All the mosquito
cells were maintained as a monolayer in T25 cell culture flasks at 28°C.
African green monkey kidney Vero E6 (ATCC CRL-1586) cells were cul-
tured inDulbecco’smodified Eaglemedium containingHEPES (DMEM-
HEPES) (Gibco) supplemented with 10% FBS, penicillin (100 U/ml; Sig-
ma-Aldrich), and streptomycin (100 g/ml; Sigma-Aldrich). The cells
were maintained as a monolayer in T25 cell culture flasks at 37°C and
5% CO2.
Generation of infectious clones and virus stocks. The wild-type
WNV lineage 2 isolate used in this study was isolated in southeastern
Europe (GenBank KC496015.1) and is referred to below as WNVGR. The
infectious clone ofWNVGR, based on the same virus isolate, was supplied
by Tamás Bakonyi from the Department of Microbiology and Infectious
Diseases, Szent IstvánUniversity, Budapest, Hungary (40). The infectious
clone is referred to below asWNVIC. A subclone of the virus was made by
PCR amplification of the NS4-3= UTR region with Phusion polymerase
(New England BioLabs), using primers FW (5=-TGGCTGAAGTCCCAG
GAACGA-3=) andRV (5=-TGGAAGTCCGAGCTCATCGCT-3=). The re-
sulting amplicon was cloned into pJET1.2 (Fermentas), and site-directed
Göertz et al.












mutagenesis was used to produce pJET1.2/subGR10SF1, withmutations
in the pseudoknot site of SL-II, with Phusion PCR using primers FW
(5=-GAAGCTCACTAGACGGTGCTGCCTGCG-3=) and RV (5=-CTAG
TGAGCTTCCGGTGGCAGCATTAATC-3=). Site-directed mutagenesis
of pJET1.2/subGR10SF1 with primers FW (5=-CTCTAGTGTGG
CACTCTGCGGAGAGTGCAG-3=) and RV (5=-CGCAGAGTGCCA
CACTAGAGTGTGGTCTGAC-3=) was used to produce pJET1.2/
subGR10SF12 with mutations in SL-II and SL-IV. The NS4-3= UTR
region of pJET1.2/subGR10SF1 or pJET1.2/subGR10SF12was cloned
using SphI-HF (New England BioLabs) and Pfl23II (Fermentas) into
WNVIC to produce WNVSF1 and WNVSF12. Virus stocks of
WNVIC, WNVSF1, and WNVSF12 were produced by transfecting
Vero cell monolayers with 800 ng infectious clone DNA using 2 l of
Lipofectamine 2000 (Invitrogen) in 6-well plates. Three days posttrans-
fection (dpt), the supernatant was harvested and used to inoculate a T75
flask of C6/36 cells seeded 1 day in advance. Six days postinfection (dpi),
the supernatant of C6/36 cells was harvested and stored at80°C. All the
viruses used in this study are from a second passage (P2).
Cell viability assay.Cellmonolayerswerewashedwith 1phosphate-
buffered saline (PBS) and lysed using passive lysis buffer (PLB) (Promega)
for 10 min at room temperature. Subsequently, CellTiter-Glo 2.0 reagent
(Promega)wasmixedwith the PLB in a 1:1 ratio and incubated in the dark
for 10min at room temperature beforemeasuring the luminescence using
a Fluostar Optima microplate reader (BMG Labtech).
Virus titrations.The 50% tissue culture infectious dose (TCID50) was
determined using an endpoint dilution assay (EPDA) on Vero cells, as
described previously (41). Briefly, Vero cell monolayers were detached
using trypsin (Gibco) and diluted in DMEM supplemented with 10%
FBS, penicillin, and streptomycin. Tenfold dilutions of the virus samples
were made in culture media, and a Vero cell suspension (1.0 105 cells)
was added in a 1:1 ratio. For each dilution, 10 l was plated at 6-fold in a
60-well Micro-Well plate (Nunc) and scored 3 dpi for the presence of
WNV by either cytopathic effect (CPE) or immunostaining using anti-E
monoclonal antibodies.
Virus growth curves. Monolayers of the indicated cell types were in-
fected in a 6-well plate at a multiplicity of infection (MOI) of 1 by adding
1 ml of diluted virus to the cells. The cells were incubated in the presence
of virus for 2 h and washed three times with 1 PBS. Two milliliters of
fresh cell culturemediumwas added, and the cells were incubated at either
37°C with 5% CO2 (Vero cells) or at 28°C (mosquito cells). At the indi-
cated times postinfection, 30 l of samples of cell culture medium were
frozen at80°C until further processing. Virus samples were titrated on
Vero cells by EPDA.
RNA isolation and Northern blotting. Total RNA was isolated from
cell monolayers using TRIzol reagent (Invitrogen) following the manu-
facturer’s protocol. For RNA isolations performed on mosquito bodies,
the bodies were homogenized in a Bullet blender using zirconium beads
(Next Advance, New York, NY) for 2 min at maximum speed. DMEM
(100l) was added, samples were centrifuged for 2min at 12,000 g, and
the pellet was homogenized in 500 l TRIzol reagent. An additional 75%
ethanol wash step was included to ensure a clean RNA pellet. The isolated
RNAwas quantified with a NanoDrop UV photospectrometer and stored
at80°C. Five micrograms of total RNA was separated by denaturing gel
electrophoresis in a 6% polyacrylamide–7 M urea–0.5 Tris-borate-
EDTA (TBE) gel for 1.45 h at a constant voltage of 150 V. The RNA was
semidry blotted on a Hybond-N membrane (Amersham Biosciences) for
60 min at a constant amperage of 0.2 A, UV cross-linked by 1 min of UV
light exposure, and hybridized overnight with digoxigenin (DIG)-labeled
probes in modified Church (0.36 M Na2HPO4, 0.14 M NaH2PO4, 1 mM
EDTA, 7% [wt/vol] SDS)-10% formamide buffer at 50°C. DIG-labeled
probes were made by PCR using Phusion polymerase (New England
BioLabs) with DIG-labeled nucleotides (Roche) (FW, 5=-GCAGTCTGC
GACAGTGCC-3=; RV, 5=-GTTGTGCAGAGCAGAAGATC-3=) using
WNVIC as a template. The blots were stained with allophycocyanin (AP)-
labeled anti-DIG (-DIG) antibodies for 30 min (11093274910; Roche) and
developed with nitroblue tetrazolium (NBT)-BCIP (5-bromo-4-chloro-3-
indolylphosphate) solution(Roche)until a sufficient signalwasachieved.The
blots were scanned with a Bio-Rad Gel Doc scanner. Quantification of band
signal intensities was performed in ImageJ by transforming the image into an
8-bit format, followed by analyzing the band intensity using the measure
function. After deducting the background signal from the sfRNA1 and
sfRNA2 band intensities, the sfRNA1/sfRNA2 ratio was determined.
RT-PCR and qRT-PCR. First-strand synthesis was performed with
500 to 1,000 ng total RNA per reaction mixture using Superscript III
(Invitrogen) and random hexamers (Roche), following the manufactur-
er’s protocol. Reverse transcription (RT)-PCRs were performed on 0.2l
cDNA using GoTaq green (Promega) according to the manufacturer’s
protocol. Quantitative RT (qRT)-PCR was performed with SYBR Select
mastermix (Applied Biosystems) on a Rotagene 3000 (Corbett Research).
Briefly, the cDNA was diluted 5-fold in double-distilled H2O (ddH2O),
and 1 l was used as a template with primers targeting either the vgRNA
(FW, 5=-TGCACTCCTAGTCCTAGTGTTTGGG-3=; RV, 5=-TCTTGAA
TGTAGCCATGAGTGCC-3=) or the C. pipiens 40S ribosomal protein S7
(rpS7) RNA (FW, 5=-ATGGTTTTCGGATCAAAGGT-3=; RV, 5=-GACG
TGCTTGCCGGAGAAC-3=) at an annealing temperature of 57°C.
Deep sequencing of small RNAs.Total RNAwas isolated as described
above, and 15 g of RNA per sample per lane was separated by gel elec-
trophoresis on 15% polyacrylamide-7 M urea-0.5TBE gels. For the se-
quencing of small RNAs fromWNVIC- and WNVSF-infected northern
European mosquitoes, the 19- to 24-nt RNAs were cut from the gel using
radioactively labeled RNA oligonucleotides and loaded in adjacent lanes
of the gel as rulers. Subsequently, the gel slices were crushed using gel
breaker tubes, and small RNAswere eluted in 800l 0.3M sodium acetate
(NaOAc), precipitated with 80% ethanol (EtOH), and dissolved in 11 l
H2O. Small-RNA deep-sequencing libraries were prepared using the
TruSeq small-RNA kit (15016914; Illumina) according to the manufac-
turer’s protocol, as described previously (21). Briefly, after adapter liga-
tion, reverse transcription, and PCR amplification, the cDNA libraries
were gel purified from 6% polyacrylamide-1 TBE gels, eluted in 500 l
0.3MNaOAc, precipitatedwith 80%EtOH, and dissolved in 11l 10mM
Tris-HCl, pH 8.5. The small-RNA library was sequenced on an Illumina
HiSeq 2500 (Baseclear, Leiden, The Netherlands), and single-end FASTQ
reads were generated using the IlluminaCasava pipeline version 1.8.3. Initial
quality assessments were performed with Baseclear using in-house filtering
protocols and the FASTQC quality control tool version 0.10.0. Further se-
quence analysis was performed on theGalaxy server (41). Adapter sequences
were removed fromeach readusing theClip tool version1.0.1 andmapped to
either theWNVIC orWNVSF1 genomewithBowtie version 1.1.2 (41). Size
profiles of the viral small RNAs were retrieved from all the mapped reads,
allowing1mismatch. For genomeprofiles, the 5= endsof the21-nt virus reads
were mapped along the viral genome.
Mosquito rearing. A C. pipiens colony originating from Brummen,
The Netherlands, was established in 2010 and maintained at 23°C and
60% relative humidity (RH) on a 16-h/8-h light-dark (L-D) cycle. The
mosquitoes were maintained in Bugdorm cages and provided with 6%
glucose solution ad libitum. Hemotek PS5 feeders (DiscoveryWorkshops)
filled with bovine or chicken whole blood (KemperKip, Uden, The Neth-
erlands) were used to administer a blood meal for egg production. Egg
rafts were allowed to hatch in tap water supplemented with Liquifry no. 1
(Interpet Ltd., Dorking, United Kingdom). The larvae were fed with a
1:1:1 mixture of ground koi food, ground rabbit food, and bovine liver
powder (Sigma-Aldrich, Zwijndrecht, The Netherlands).
In vivo infections. (i) Infectious blood meal. Two days before blood
feeding, the mosquitoes were starved by providing them with a tissue
soaked inwater.Onemilliliter ofwhole chicken blood (Kemperkip,Uden,
The Netherlands) was mixed with 1 ml virus solution in Leibovitz-L15
supplementedwith 10%FBS to a final concentration of 4.0 107 TCID50/
ml. Two- to 7-day-old mosquitoes were allowed to feed ad libitum
through a Parafilm membrane using a Hemotek feeder in a controlled
dark room at 24°C and 70% RH for 1 h. After blood feeding, the mosqui-
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toes were anesthetized with 100% CO2, and engorged females were se-
lected on a CO2 pad.
(ii) Intrathoracic injections. Two- to 5-day-old female mosquitoes
were anesthetizedwith 100%CO2andplacedonaCO2pad, and710
3 or
7  102 TCID50 of virus was injected in a total volume of 69 nl using a
Drummond Nanoject II Auto-Nanoliter Injector (Drummond Scientific
Company). Blood-fed or injected mosquitoes were incubated at 28°C on a
16-h/8-h L-D cycle and fed with 6% sugar water during the course of the
experiment. At 14 dpi (or as indicated), mosquitoes were anesthetized with
100%CO2, and the legs andwings were removed from themosquito bodies.
Saliva from the mosquitoes was collected by putting the proboscis in 5 l of
3% sugar water, 50% FBS for 45 min. After salivating, the mosquito bodies
were added to a 1.5-ml Eppendorf tube containing 0.5-mm zirconiumbeads
(NextAdvance,NewYork,NY) and frozen at80°C. Fifty-fivemicroliters of
HEPES-buffered DMEM–10% FBS–penicillin/streptomycin–gentamicin
was added to the saliva samples. Themosquito homogenates and saliva sam-
ples were stored at80°C until further processing.
WNV infectivity assay. WNV infectivity assays were performed as
described previously (42). Briefly, mosquito bodies were homogenized in
a Bullet blender (Next Advance, New York, NY; two rounds of 2min each
at maximum speed); 100 l of HEPES-buffered DMEM–10% FBS–PS–
gentamicin was added to themosquito homogenates, and 30l mosquito
homogenate was used to inoculate Vero cell monolayers in 96-well plates.
For saliva samples, 30 l saliva in DMEM-10% FBS-PS-gentamicin was
used to inoculate a Vero cell monolayer in a 96-well plate. At 3 dpi, the
wells were scored for the presence of virus by CPE and immunostaining
using anti-E monoclonal antibodies (43, 44).
RNA structure modeling in silico. Secondary structures were folded
using the Mfold Web server with standard settings and flat exterior loop
type (45). The secondary RNA structure was visualized using the VARNA
RNA editing package (46). Tertiary-structure folding was performed us-
ing the RNAComposer Web server with standard settings (47). The ter-
tiary RNA structure was visualized using the PyMOL viewer (48).
Statistics. All statistical analyses were performed in GraphPad Prism
5. Significant differences between virus infection and transmission rates
were determined by Fisher’s exact test ( 	 0.05). t tests were performed
using a 95% confidence interval. The D’Agostino and Pearson omnibus
normality test was used to check forGaussian distributions. In caseswhere
the data did not follow a Gaussian distribution, a Mann-Whitney U test
was used ( 	 0.05) to replace the t test. Statistics on the virus growth
curves were done using a two-way analysis of variance (ANOVA).
RESULTS
An sfRNA1-deficient clone of WNV is not attenuated in vitro.
WNV mutants that are deficient in the formation of full-length
sfRNA (sfRNA1) cause progressively less CPE in cell culture when
only shorter and/or less abundant sfRNA species can be produced
(25, 29). To study the effects of sfRNA on transmission indepen-
dent of effects on replication and cytopathicity, we used a mutant
that is deficient only in sfRNA1. This mutant has previously been
shown to have little effect on the replication rate and cytopathicity
of WNV, as opposed to sfRNA1-sfRNA2-deficient mutants,
which are attenuated in both insect and invertebrate cell lines (25,
29, 31). An infectious clone of WNV (WNVIC) was compared to
an sfRNA1-deficient infectious clone of WNV (WNVSF1) that
was generated by mutating the top loop of SL-II (Fig. 1A). The
FIG 1 Generation and characterization of an sfRNA1-deficient WNV. (A) Two-dimensional (2D) RNA structure model of the 3= UTR/sfRNA of WNVGR. The
lines indicate pseudoknot interaction; the nucleotides mutated in WNVSF1 are shaded. (B) Northern blot of RNA harvested from Vero cells infected with
WNVIC or WNVSF1 or mock treated. Numbers at right are kilobases. (C) Vero cells were infected with WNVGR, WNVIC, or WNVSF1 at an MOI of 1.
Supernatants were taken at 0, 1, 2, 3, and 4 dpi and titrated by EPDA. Shown are the mean titers of two independent experiments
 standard errors of the mean
(SEM). Statistics were done using a two-way ANOVA. (D) Vero cells were infected with WNVGR10, WNVIC, or WNVSF1 at an MOI of 5, and at the indicated
times, the cell viability was measured by CellTiter-Glo assay. hpi, hours postinfection.
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wild-type virus (WNVGR) was used for comparison in the growth
curve and cell viability experiments. As expected, Northern blot
analysis of RNA isolated from Vero cells using a 3= UTR-specific
probe indicated that WNVIC predominantly produced sfRNA1.
Conversely, WNVSF1 produced only sfRNA2 as a result of mu-
tated SL-II, resulting in XRN1 stalling on SL-IV (Fig. 1B). An
unexpected additional band was observed for WNVIC between
sfRNA1 and sfRNA2, which was not produced in cells infected
with WNVSF1 (Fig. 1B). Comparison with the flaviviruses
Usutu virus (USUV) and WNV New York 1999 (WNVNY99)
demonstrated that the size of full-length sfRNA from WNVIC
was similar, confirming that the top band is sfRNA1 (data not
shown). One-step growth curves in Vero cells demonstrated that
WNVSF1 had growth kinetics similar to those ofWNVIC and the
wild-typeWNVGR virus isolate (Fig. 1C). In addition, WNVSF1
caused a level of CPE comparable to that of WNVGR andWNVIC,
as observed by a steady decrease in cell viability between 1 and 3
dpi (Fig. 1D). These results validate WNVSF1 as a model to
study the effects of sfRNAwithout interference from altered cyto-
pathicity and/or replication.
An sfRNA1-deficient WNV replicates efficiently in RNAi-
competent mosquito cells. To investigate whether sfRNA1 is re-
quired for replication of WNV in mosquito cells, one-step virus
growth curves were performed on C. tarsalis Cx.t, A. albopictus
U4.4, andDicer2-deficientA. albopictusC6/36 cells (49).WNVGR,
WNVIC, andWNVSF1 replicated similarly in all three mosquito
cell lines, withmaximum titers reaching4 108 TCID50/ml at 3
dpi in U4.4 cells and1 108 TCID50/ml at 4 dpi in both C6/36
and Cx.t cells (Fig. 2A); however, WNVSF1 reached slightly
lower titers at 3 and 4 dpi in U4.4 and 4 dpi in C6/36 cells. These
results indicate that sfRNA1 is not required for efficient WNV
replication in mosquito cells, consistent with the observations in
mammalian cells (Fig. 1C). Furthermore, the similar virus titers in
RNAi-competent Cx.t and U4.4 cells compared to the RNAi-de-
ficient C6/36 cells indicate that there is no obvious effect of an
active RNAi response on either WNVIC or WNVSF1 produc-
tion. Northern blot analysis indicated that abundant levels of
sfRNA1, but low levels of sfRNA2, are produced in WNVIC-in-
fectedU4.4, C6/36, andCx.t cells (Fig. 2B).However, cells infected
with WNVSF1 produced large amounts of sfRNA2 and much
lower levels of sfRNA1, particularly in the Cx.t cells. Quantifica-
tion of sfRNA1 and sfRNA2 signal intensities demonstrated an
sfRNA1/sfRNA2 ratio of 3 for WNVIC-infected versus 0 to 0.4
for WNVSF1-infected cells (Fig. 2C). These results indicate that
WNVSF1 is largely defective in sfRNA1 production and can suc-
cessfully replicate in RNAi-competent mosquito cells.
Viral siRNAs derived from the 3= UTR are produced in NA
and NWE C. pipiens mosquitoes infected with WNVGR. While
sfRNA suppresses reporter-based RNAi in mosquito cells (23, 37)
and in vivo in mosquitoes and interacts with the RNAi machinery
in mammalian cell lines (38), it is still unclear whether during an
in vivo infection in mosquitoes the 3= UTR sfRNA is processed by
the RNAi machinery. To investigate if WNVGR 3= UTR-derived
small RNAs are produced in C. pipiens mosquitoes, we analyzed
the vsRNA profiles generated in a set of independent experiments
with a wild-type WNV lineage II isolate (WNVGR) in northwest-
ern European (NWE) andNorthAmerican (NA)C. pipiens strains
(Fig. 3) (21). Size distributions of vsRNAs showed that 21-nt viral
FIG 2 One-step growth curves and sfRNA production in mosquito cells. (A) A. albopictusU4.4 and C6/36 and C. tarsalis Cx.t cells were infected with WNVGR,
WNVIC, or WNVSF1 at an MOI of 1. Supernatants were taken at 0, 1, 2, 3, and 4 dpi and titrated by EPDA. Shown are the mean titers 
 SEM from two
independent experiments. The statistics were done using a two-way ANOVA. *, P 0.05. (B) Northern blot of RNA isolated 4 dpi fromU4.4, C6/36, or Cx.t cells
using a 3= UTR-specific probe. Numbers at right are kilobases. (C) Mean sfRNA1/sfRNA2 signal ratio. Shown are the mean results and SEM from two
independent experiments. The statistics were performed using a two-tailed unpaired t test.
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siRNAs (vsiRNAs) were highly abundant and that no obvious
25-nt vsRNAs were produced (Fig. 3A), indicating that no
WNV-specific piRNAs are produced in C. pipiens mosquitoes. A
small shoulder of 25- to 32-nt sRNAs was present; however, these
sRNAs did not have the 10A-biased piRNA signature (21). Hot-
and cold-spot analysis of the 21-nt vsRNAs along the WNV ge-
nome indicated that vsiRNAs were produced across the whole
length of the genome (Fig. 3B). NAmosquitoes produced smaller
amounts of vsiRNAs and mapped differentially across the ge-
nome, indicating that different mosquito populations can influ-
ence the sRNA profile. Detailed hot- and cold-spot analysis of the
viral 3= UTR showed that in both NWE and NA mosquitoes two
hot spots were present in SL-III and the 3= SL, respectively, while
NAmosquitoes also displayed a hot spot in SL-IV (Fig. 3C). These
results show that the 3= UTR of the WNVGR gRNA is targeted by
the RNAi machinery and processed into 21-nt vsRNA, indicating
that sfRNA might be processed by the RNAi machinery in vivo.
C. pipiens mosquitoes mount an active RNAi response
against wild-type and sfRNA-deficient WNV. Our experiments
clearly show that an sfRNA-deficient mutant replicates efficiently
in RNAi-competent mosquito cells, although the 3= UTR appears
to be processed by the RNAi machinery in vivo. To investigate if
sfRNA is a substrate for Dicer and/or influences the mosquito
RNAi response in vivo, 19- to 24-nt small-RNA populations were
sequenced from pools (n  12) of WNVIC or WNVSF1 blood
meal-infected mosquitoes at 14 dpi (Fig. 4). RNAs larger than 25
nt were excluded from deep sequencing, since it was previously
shown that Culex mosquitoes do not produce 25- to 30-nt vpiR-
NAs (Fig. 3A) (14, 21). To rule out potential effects of differenti-
ation between the two mosquito pools, we first verified the virus
titers and vgRNA levels at 14 dpi. The virus titers in the two pools
of mosquitoes were marginally different, with a slightly but not
significantly higher titer for WNVIC (1.1  10
6 versus 6.3  105
TCID50/ml; P	 0.272) (Fig. 4A), while qPCR on the vgRNAdem-
onstrated that the numbers of viral genome copies were similar
(Fig. 4B). Northern blot analysis of total RNA isolated from pools
of WNV-positive mosquitoes confirmed that in mosquitoes, as
well, WNVIC predominantly produced sfRNA1 while WNVSF1
FIG 3 Deep sequencing of siRNAs fromWNVGR-infectedNorthAmerican andnorthwestern Europeanmosquitoes that target the 3=UTR. (A) Size distributions
of 15- to 32-nt small RNAs mapping to the viral genome of WNVGR normalized to the total number of clipped reads in the library. (B) Twenty-one-nucleotide
small-RNA reads were aligned to the viral genome and normalized against the total number of clipped reads in the library. Positive-strand reads are displayed in
blue and negative-strand reads in red. (C)Detailed view of the 21-nt small-RNA distribution on the 3=UTR. The arrows indicate the vsiRNAhot spots that target
the 3= UTR in both mosquito colonies.
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FIG 4 Small-RNA sequences ofWNVIC orWNVSF1 blood-fedmosquitoes. (A)WNV titers ofmosquito bodies used for small-RNA sequencing. The statistics
were performed using an unpaired t test. The error bars indicate SEM. (B)WNV genome copies in RNA samples used for small-RNA sequencing determined by
qRT-PCR. (C) Northern blot from the same RNA sample that was used for deep sequencing using a 3= UTR-specific probe. Numbers at right are kilobases. (D
and E) Size distributions of small-RNA reads mapping to the viral genome of WNVIC or WNVSF1 blood-fed mosquitoes normalized to the total number of
reads (D) or the total number of viral reads (E) in the library. (F and G) The 5= ends of the reads were aligned to the viral genome and normalized against the
number of viral reads. The positive-strand (F) and negative-strand (G) reads weremapped forWNVIC andWNVSF1. (H and I) Detailed view of the 21-nt RNA
distribution on the 3= UTR for the positive strand (H) and the negative strand (I). The green arrows indicate siRNA hot spots that are sfRNA specific. The blue
arrow indicates the presence of KUN-miR-1.
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produced only sfRNA2 (Fig. 4C). The vsRNA size distributions
were very similar inWNVIC- andWNVSF1-infectedmosquitoes
(Fig. 4D and E). A distinctive peak of 21-nt vsRNAs was observed
for both WNVIC and WNVSF1 (Fig. 4D and E). This 21-nt vs-
RNA population was present on both the positive and negative
strands, indicating that they can be regarded as vsiRNAs. WNVIC
produced slightly higher total levels of vsiRNAs than WNVSF1
(Fig. 4D), although when normalized to the number of viral reads
(Fig. 4E), therewas no difference in the percentages of 21-nt reads.
This indicates that the difference in percentages of total reads can
be explained by the slightly elevated titer of WNVIC, although the
numbers of viral genome copies were similar (Fig. 4A and B).
Next, we investigated whether sfRNA affected the genome distri-
bution of vsRNAs by mapping the 21-nt reads along the vgRNA
for the positive (Fig. 4F) and negative (Fig. 4G) strands. The
vsiRNA genome distributions were highly similar between
WNVIC and WNVSF1 on both the positive and negative
strands, as illustrated by the mirrored hot- and cold-spot plots
(Fig. 4F and G), providing no direct evidence that sfRNA1 inter-
feres with the antiviral RNAi response in vivo.
sfRNA-derived vsiRNAs should be positive-strand biased due
to the nature of sfRNA biogenesis (25). Indeed, two distinct hot
spots that occur on the positive strand in WNVIC-infected mos-
quitoes, but not on the positive strand of WNVSF1-infected
mosquitoes (Fig. 4H) or on the negative strands of both viruses,
were identified (Fig. 4I). Hot spots 10642 and 10976 were present
only in WNVIC-infected mosquitoes and not in mosquitoes in-
fected with WNVSF1, indicating that the vsiRNAs from these
hot spots are derived from sfRNA1. Interestingly, these sfRNA-
specific hot spots cooccurred with predicted secondary structures
of SL-III (hot spot 10642) and the 3= SL (hot spot 10976) (Fig. 4H
and 5A). Finally, Kunjin virus miR-1 (KUN-miR-1), previously
discovered in vitro (50), was also found at position 11030, indicat-
ing that KUN-miR-1 could have a potential function in vivo in
mosquitoes. These results show for the first time that sfRNA is
processed by the mosquito RNAi machinery and that an sfRNA1-
defective WNV mutant has a differential vsiRNA profile in the
viral 3= UTR.
3D modeling of WNV sfRNA reveals SL-III and the 3= SL as
accessible dsRNA substrates. Our small-RNA deep-sequencing
data clearly show that sfRNA is processed by the RNAi machinery
into vsiRNAs but do not explain why vsiRNA hot spots occur in
certain RNA structures. To better understand why some regions
of the 3=UTR/sfRNA are preferentially targeted by RNAi, a three-
dimensional (3D) model of the WNVGR 3= UTR/sfRNA was cre-
ated using RNAComposer (47) (Fig. 5). Each secondary structure
was color coded, and the two most significant vsiRNA hot spots
are colored green in Fig. 5A. The pseudoknot interactions in the
XRN1/Pacman stalling structures SL-II and SL-IV result in very
tight tertiary folding (Fig. 5B), potentiallymaking these structures
inaccessible to processing by host nucleases. In contrast, SL-III
sticks out of the 3= UTR coil and thus could present an accessible
dsRNA substrate for Dicer and/or other nucleases. Similarly tight
tertiary folding occurs for the dumbbell RNA structures DB1 and
DB2 (Fig. 5C), which also display tight folding via pseudoknot
interactions with the main coil of the 3= UTR/sfRNA. The 3= SL,
FIG 5 Three-dimensional RNA structuremodel of sfRNA revealing that SL-III and the 3= SL aremore accessible to themosquitoRNAimachinery. (A) Schematic
presentation of the WNVGR sfRNA secondary RNA structure with projections of the vsiRNA hot spots. Pseudoknot interactions are indicated by lines, and
pseudoknot-interacting bases are colored red. sfRNA-specific vsiRNAs are indicated in green, and each SL andDBwas given a separate color. (B and C) 3DRNA
structure model of the first 240 nt (B) and last 288 nt (C) of WNV sfRNA. The colors match the color scheme of the secondary structures in panel A.
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however, sticks out of the 3= UTR coil and thus could also present
an accessible dsRNA substrate. These results provide insight into
the tertiary fold of the 3= UTR/sfRNA and explain why vsiRNAs
are mostly derived from SL-III and the 3= SL.
sfRNA1 determines WNV transmission by mosquitoes. The
conservation of sfRNA production in all flaviviruses suggests an
important biological function in both mammalian and insect
hosts. Importantly, the sequence of the flaviviral 3= UTR can be
phylogenetically divided based on the virus vector species (33),
indicating a role for sfRNA in infection and/or transmission of the
arthropod vector. To investigate if sfRNA is important for dissem-
ination and transmission of WNV, C. pipiens mosquitoes were
allowed to feed for 1 h on a blood meal containing either WNVIC
or WNVSF1. After 14 days, the titer of WNV in the mosquito
bodies was determined by EPDA, and the presence ofWNV in the
saliva was determined by inoculating Vero cells (Fig. 6A). Impor-
tantly, the infection rate, as determined by the percentage of en-
gorgedmosquitoes with a measurable virus titer, was significantly
lower for WNVSF1 than for WNVIC (13% versus 32%; P 
0.001) (Fig. 6B and Table 1 ). In addition, the transmission rate, as
determined by the percentage of saliva-positivemosquitoes out of
the total number of engorged mosquitoes, was significantly lower
for mosquitoes infected with WNVSF1 than for mosquitoes in-
fected with WNVIC (10% versus 26%; P  0.001) (Fig. 6B and
Table 1), indicating that sfRNA1 production was important for
transmission when mosquitoes were orally infected. Dissemina-
tion rates, as determined by the percentage of saliva-positivemos-
quitoes out of the number of virus-positive mosquitoes, was not
affected by sfRNA1 (82% versus 79%; P 	 1.000) (Fig. 6B and
Table 1). This indicates that sfRNA1mainly affects infection of the
midgut and consequently increases the transmission rate. The vi-
ral titers of mosquito bodies that were positive for the presence of
FIG 6 Transmission and infection rates of WNVIC and WNVSF1 in C. pipiens mosquitoes after an infectious blood meal. (A) Schematic overview of the
experimental procedure. (B) Infection (Bodies), transmission (Saliva), and dissemination (Saliva/Bodies) rates of C. pipiens mosquitoes infected through an
infectious bloodmeal containingWNVIC (n	 140) orWNVSF1 (n	 149). The infection, transmission, and dissemination rates are presented as percentages
of the total number ofmosquitoes. The data represent cumulative numbers from four independent experiments. The statistics were performed using Fisher exact
tests. ns, not significant. (C) Titers of WNV-positive mosquito bodies and saliva samples of WNVIC or WNVSF1 blood meal-infected mosquitoes. Shown are
the mean titers
 SEM. The statistics were performed using a two-tailed unpaired Mann-Whitney U test.
TABLE 1 Four replicate blood-feeding experiments demonstrate that sfRNA determines the infection and transmission rates of WNV in C. pipiens
mosquitoesa
Virus Replicate n Positive bodies (no.) Positive saliva (no.) Infection (%) Transmission (%) Dissemination (%)
WNVIC 1 33 11 11 33 33 100
2 39 20 14 51 36 70
3 24 5 4 21 17 80
4 44 9 8 20 18 89
Total 140 45 37 32 26 82
WNVSF1 1 37 8 6 22 16 75
2 40 3 3 8 8 100
3 23 2 2 9 9 100
4 49 6 4 12 8 67
Total 149 19 15 13 10 79
a Shown are infection, transmission, and dissemination rates of C. pipiens mosquitoes orally infected with either WNVIC or WNVSF1. In addition, the sample size (n) as the
number of engorged females after a blood meal and absolute numbers of positive bodies and saliva samples are shown for each replicate.
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virus by EPDA were not significantly different between WNVIC
andWNVSF1 (P	 0.360) (Fig. 6C). However, the viral titers in
the saliva were significantly higher for WNVIC-infected than for
WNVSF-infected mosquitoes (2.2  105 versus 8.0  103; P 
0.01) (Fig. 6C). These results suggest that sfRNA1 determines
WNV transmission by increasing the overall infection rates and by
boosting viral titers in the mosquito saliva.
sfRNA1 is a key driver to overcome themosquitomidgut in-
fection barrier. The infection rate of mosquitoes and the sub-
sequent dissemination to the salivary glands are important pa-
rameters for arbovirus transmission (11). Clearly, WNVSF1
displayed significantly reduced transmission rates, which could
be (i) the result of reduced virus dissemination through an
effect of sfRNA1 on a postmidgut barrier or (ii) the conse-
quence of reduced initial infection rates. Although our data sug-
gest that the main effect of sfRNA occurs in the midgut, we dis-
criminated between these two possibilities by intrathoracic
injections of C. pipiensmosquitoes with 7 103 TCID50 of either
WNVIC or WNVSF1. In this way, the midgut barriers are by-
passed to allow the study of postmidgut virus dissemination and
transmission. At 14 dpi, an infection rate of 100%was achieved for
mosquitoes injected with either WNVIC or WNVSF1 (Fig. 7A
and Table 2), suggesting that the two viruses are equally capable of
establishing a systemic, fully disseminated infection when the
FIG 7 Intrathoracic injections of C. pipiens mosquitoes with WNVIC and WNVSF1. (A) Infection (Bodies), transmission (Saliva), and dissemination
(Saliva/Bodies) rates of WNVIC (n	 34) and WNVSF1 (n	 50) in C. pipiensmosquitoes after intrathoracic injections with 7.7 10
3 TCID50 per mosquito.
The data represent cumulative numbers from three independent experiments. The statistics were performed using Fisher exact tests. (B) Titers ofWNV-positive
mosquito bodies and saliva samples frommosquitoes injectedwithWNVIC orWNVSF1. Shown are themean titers
 SEM.The statistics were performed using
a two-tailed unpaired Mann-Whitney U test. (C) Transmission rates in C. pipiensmosquitoes of WNVIC or WNVSF1 after intrathoracic injection at 1, 6, and
14 dpi. The statistics were performed using Fisher exact tests. (D) Infection and transmission rates at 7 dpi in C. pipiensmosquitoes after intrathoracic injection
of a low dose (7.7 102 TCID50 versus 7.7 10
3 TCID50) of WNVIC or WNVSF1. The statistics were performed using Fisher exact tests.
TABLE 2 Three replicate intrathoracic injection experiments indicate no effect of sfRNA on postmidgut dissemination of WNV in C. pipiens
mosquitoesa
Virus Replicate n Positive bodies (no.) Positive saliva (no.) Infection (%) Transmission (%) Dissemination (%)
WNVIC 1 15 15 15 100 100 100
2 13 13 11 100 85 85
3 6 6 6 100 100 100
Total 34 34 32 100 94 94
WNVSF1 1 19 19 17 100 89 89
2 21 21 18 100 86 86
3 10 10 10 100 100 100
Total 50 50 45 100 90 90
a Shown are infection, transmission, and dissemination rates of C. pipiens mosquitoes that were intrathoracically injected with either WNVIC or WNVSF1. In addition, the sample
size (n) and absolute numbers of positive bodies and saliva samples are shown for each replicate.
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midgut infection barrier is bypassed. Next, the saliva of all mos-
quitoes was tested for the presence of WNV. There was no signif-
icant difference in transmission rates (94% versus 90%; P 	
0.696) (Fig. 7A and Table 2) or dissemination rates (94% versus
90%; P 	 0.696) (Fig. 7A) between WNVIC and WNVSF1, de-
spite a significant difference in average body titers (WNVIC, 2.4
107; WNVSF1, 4.4 106; P 0.001) (Fig. 7B). Titration of the
mosquito saliva showed no significant differences (WNVIC, 4.4
105;WNVSF1, 1.0 106;P	 0.873). Additionally, at 1, 6, and 14
dpi, no significant difference between the transmission rates of
WNVIC and WNVSF1 was observed (1 dpi, 14% versus 11%
[P	 1.000]; 6 dpi, 100% versus 100% [P	 1.000]; 14 dpi, 100%
versus 86% [P	 0.492]) (Fig. 7C). To rule out the possibility that
the lack of difference betweenWNVIC andWNVSF1 was due to
a viral dose that was too high, we repeated the experiment with a
10-fold-lower injection dose of 7 102 TCID50 per mosquito and
scored the infection and transmission rates at an earlier time point
of 7 dpi (Fig. 7D). Again, no difference between WNVIC and
WNVSF1 was observed in either the infection or transmission
rate, indicating that there is no clear postmidgut effect of sfRNA1
on transmission. These results demonstrate that sfRNA1 does not
play a determining role in postmidgut dissemination to the sali-
vary glands. Instead, sfRNA1 is vital to efficiently overcome the
midgut infection and/or escape barrier, resulting in enhanced vi-
rus dissemination and subsequent transmission.
An sfRNA1-sfRNA2-deficient WNV has attenuated replica-
tion inCulex cells anddecreased transmissionbyCulexmosqui-
toes.We showed that sfRNA1 is required for successful passing of
the mosquito midgut barrier, but WNVSF1 still produces the
shorter sfRNA2. To investigate whether combined abrogation of
both sfRNA1 and sfRNA2 production would further attenuate
WNV, we generated an infectious clone with mutations in both
SL-II and SL-IV (WNVSF12) (Fig. 8A). The mutation intro-
duced in SL-IV resides in the conserved three-way-junction that
was previously shown to be important for XRN1 resistance (30).
Northern blot analysis of RNA isolated fromC6/36mosquito cells
infected with WNVIC, or WNVSF12 demonstrated that the
double mutant indeed fails to produce sfRNA1 and sfRNA2 (Fig.
8B). The effect of sfRNA1-sfRNA2 deletion on replication was
tested by performing growth curves on Cx.t and Vero cells with
WNVIC and WNVSF12. No difference in replication was ob-
served in Vero cells, although WNVSF12 presented slightly
lower titers (Fig. 8C). However, in Cx.t cells, WNVSF12 was
severely attenuated in virus growth, indicating that sfRNA is im-
portant for successful replication in Culex (Fig. 8D). Since we
showed that deletion of sfRNA1 production results in decreased
transmission rates in C. pipiens after an infectious blood meal, we
hypothesized that combined abrogation of sfRNA1 and
sfRNA2 production further attenuates WNV in mosquitoes. To
test this hypothesis,C. pipiensmosquitoeswere given an infectious
blood meal with 5.0  106 TCID50/ml of either WNVIC or
WNVSF12 (Fig. 8E) (Table 3). The titer of this bloodmeal was
slightly lower than in the previous experiments due to a lower
plateau titer of WNVSF12 in C6/36 cells. WNVIC-infected
mosquitoes reached an infection rate of 16% and an14% trans-
mission rate, consistent with the data in Fig. 6. However, the
WNVSF12 blood-fed mosquitoes reached significantly lower
infection (2%; P	 0.004) and transmission (2%; P	 0.04) rates,
indicating that sfRNA1 and sfRNA2 are vital for infection of mos-
quitoes. Sequencing of the 3= UTR of the WNVSF12-infected
mosquitoes showed that the mutations in SL-II and SL-IV were
still present, indicating that no reversions occurred (data not
shown). In conclusion, these results provide the first evidence that
sfRNAplays an important role inmosquito transmission ofWNV,
which could underpin the strict conservation of sfRNA produc-
tion by flaviviruses.
DISCUSSION
Flavivirus epidemics occur as a result of a complex three-way in-
terplay between virus, host, and vector and are influenced by a
range of environmental factors. Where and when flavivirus out-
breakswill occur cannot be readily predicted, but it is clear that the
ability of a mosquito population to transmit a certain flavivirus is
essential for efficient viral spread from one vertebrate host to an-
other. This vector competence is primarily dictated by the specific
virus-vector combination, yet the viral determinants of vector
competence are not well defined. ForWNV02, it has been reported
that a single amino acid change in the envelope glycoprotein E
resulted in increased mosquito transmission rates compared to
the original NY99 strain (51). This example illustrates that flavivi-
ral products (i.e., viral proteins and viral RNA) may determine
vector competence by overcoming infection barriers to establish a
transmissible infection in the mosquito (52).
Here, we have identified a novel determinant of WNV vector
competence, a noncoding viral RNA whose abundant production
in infected cells is widely conserved in the large group of flavivi-
ruses. This sfRNA, as well as the flavivirus 3= UTR it is derived
from, contains various conserved RNA structures that may influ-
ence virus transmission by the arthropod vector (35, 53). sfRNA
production is highly conserved among all members of the genus
Flavivirus, including the NKVFs, ISFs, TBFs, and MBFs (25, 35,
36). Despite the many functions of sfRNA described in mamma-
lian cells, the biological significance for sfRNA production in the
arthropod vector has remained unknown (35). We now demon-
strate that sfRNA determines WNV transmission by C. pipiens
mosquitoes. An sfRNA1-deficientWNVmutant, WNVSF1, was
attenuated in the mosquito and had significantly decreased infec-
tion and transmission rates. A mutant deficient in sfRNA1 and
sfRNA2, WNVSF12, was also attenuated for replication in
Culex cells and demonstrated decreased transmission and infec-
tion rates in C. pipiensmosquitoes after an infectious blood meal.
From these studies, we conclude that sfRNA is produced abun-
dantly in the mosquito to facilitate efficient transmission to the
next host.
It has been firmly established that infection of and escape from
midgut epithelial cells present crucial barriers for arbovirus trans-
mission (recently reviewed in reference 12). Our results show that
sfRNA affects the transmission rate at the level of the mosquito
midgut, since WNV transmission was negatively affected by
sfRNA deficiency when the virus was administered through an
infectious blood meal but not after intrathoracic injection. After
administration through intrathoracic injections, the infection and
transmission rates between WNVIC and WNVSF1 were not sig-
nificantly different at all tested virus doses and time points, al-
though we did observe a slight difference in the overall virus titer
in the mosquito bodies. This may be an indication of a potential
additional postmidgut effect of sfRNA on virus dissemination,
which is supported by the lower titers in the saliva for WNVSF1
after infection via an infectious blood meal. However, the trans-
mission rates of wild-type and sfRNA-defective WNV in the in-
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jection experiment were always close to 100%, and no significant
difference in the virus titer in the saliva was observed.
Several intracellular mechanisms could be involved in estab-
lishing the mosquito midgut barrier against arbovirus infection,
such as RNAi, Toll/IMD/JAK-STAT signaling pathways, or apop-
tosis. The importance of antiviral RNAi in midgut cells for virus
transmission and population diversity has been shown convinc-
ingly in Culex mosquitoes (13, 14). We aimed to determine the
strength of the mosquito RNAi response by analyzing the vsiRNA
reads relative to the viral genome in a direct comparison between
WNVIC and WNVSF1. The abundance of vsiRNA is dependent
on (i) the efficiency of the putative viral RNAi suppressor function
of sfRNA and (ii) the amount of available viral dsRNA substrate in
the mosquito body, which is a function of viral RNA replication
and thus dependent on the success of RNAi suppression. In our
study, we found no direct correlation between the expression of
sfRNA1 and the abundance of (v)siRNAs produced in vivo. We
cannot formally exclude the possibility that sfRNA1 facilitates
WNV replication by RNAi suppression at an early stage so that
later more viral dsRNA can be processed into vsiRNA, but the
FIG 8 Transmission and infection rates of C. pipiens infected with WNVIC and WNVSF12. (A) 2D RNA structure model of SL-II and SL-IV of WNVGR.
Pseudoknot interaction is indicated by the lines; the nucleotides mutated in WNVSF12 are shaded. The arrows indicate the starting points of sfRNA1 and
sfRNA2. (B) Northern blot of RNA harvested from C6/36 cells infected with WNVIC or WNVSF12. (C and D) Vero (C) or Cx.t (D) cells were infected with
WNVIC or WNVSF12 at an MOI of 1. Supernatants were taken at 0, 1, 2, 3, and 4 dpi and titrated by EPDA. Shown are the mean titers of two replicate
samples
 SEM. (E) Infection (Bodies), transmission (Saliva), and dissemination (Saliva/Bodies) rates of C. pipiensmosquitoes infected through an infectious
bloodmeal containingWNVIC (n	 73) orWNVSF12 (n	 83). The infection, transmission, and dissemination rates are presented as percentages of the total
number of engorged female mosquitoes. The data represent cumulative numbers from three independent experiments. The statistics were performed using
Fisher exact tests.
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similar levels of WNVIC and WNVSF1 viral genomic RNAs in
infected mosquitoes do not support this.
The effect of sfRNA on midgut infection most likely occurs
during initial infection, which takes place in a small number of
cells (54). This “single-cell” interaction requires very high-resolu-
tion sequence data to detect potential RNAi suppression by
sfRNA, which can explain why we did not find this correlation in
our experiments. Sequencing of individual midguts of WNVIC
and WNVSF1 blood-fed mosquitoes could provide more detail
on the mechanism of interplay between the RNAi response and
sfRNA production in the mosquito midgut. A recent study
showed that sfRNAmildly suppressed the dsRNA-induced silenc-
ing in Culex quinquefasciatus mosquitoes infected with Kunjin
virus (38). The silencing suppression was demonstrated to be sig-
nificant, although the difference between the wild-type and the
sfRNA-deficient virus was not large. Since complete knockdown
of RNAi is associated with increased mosquito mortality upon
arbovirus infection, it is quite possible that sfRNA only mildly
modulates the RNAi response to facilitate virus transmission
without negatively affecting mosquito fitness (38).
Thus, because vsiRNA abundance cannot provide conclusive
evidence for RNAi suppression by sfRNA, we reasoned that ana-
lyzing the distribution of the vsiRNA on the viral genome would
be more informative to reveal potential differences between
WNVIC and WNVSF1. However, sfRNA also did not affect the
genome distribution of vsiRNAs on either the positive or negative
strand of the WNV genome. Despite the clear importance of
sfRNA in WNV transmission by the mosquito, WNVSF1 repli-
cated equally efficiently in RNAi-competent Cx.t and U4.4 cells,
suggesting that the observed effect of sfRNA on transmission in
vivo may be independent of the RNAi response.
sfRNAwas previously demonstrated to be a substrate for Dicer
in vitro and able to suppress dsRNA- and short hairpin RNA
(shRNA)-induced RNAi silencing in A. albopictus U4.4 and Dro-
sophilamelanogaster S2 cells (37). Detailed analysis of the vsiRNAs
thatmapped to the 3=UTR region ofWNVIC andWNVSF1 now
show for the first time that sfRNA is processed into vsiRNAs in
vivo in mosquitoes, as demonstrated by two sfRNA-specific hot
spots in the 3= UTR. The hot spot in SL-III of the 3= UTR was
consistently found in independent experiments in two different
mosquito colonies. However, the same hot spot was not found in
USUV-infected C. pipiens mosquitoes (reference 21 and data not
shown), even though SL-III is present in the 3= UTR of USUV.
Analysis of theWNVGR 3=UTR sequence by VMir did not predict
either of the two hot spots as potential miRNAs, while it did pre-
dict the presence of the previously discovered KUN-miR-1 that is
derived from the 3= SL (50, 55, 56) (data not shown). Additionally,
alignment of the SL-III regions from the 3= UTRs of several flavi-
viruses from the Japanese encephalitis virus (JEV) serogroup (in-
cluding WNV, USUV, JEV, and Kunijn virus) showed that the
sequence of this hot spot is poorly conserved (data not shown).
This indicates that the SL-III-derived viral small RNA is unlikely
to have an important biological function as anmiRNA/siRNA but
leaves open the possibility that processing of SL-III by Dicer may
ultimately have an effect on virus dissemination in the mosquito
midgut, e.g., via an RNA decoymechanism. The hot spot in the 3=
SL occurred only in WNVIC-infected mosquitoes and not in
WNVSF1-infectedmosquitoes, indicating that this small RNA is
derived from sfRNA1 even though sfRNA2 also contains the 3= SL
and is produced by WNVSF1. Perhaps the absence of sfRNA1
decreases the amount of substrate to be processed into small
RNAs. Alternatively, the different folding of the shorter sfRNA2
compared to that of sfRNA1 results in different processing by the
RNAi machinery.
When the 3D RNA structure of sfRNA is modeled, both SL-III
and the 3= SL are clearly sticking out of the compact fold of the
predicted sfRNA tertiary structure. These exposed stem-loops
could potentially make them easily accessible substrates for Dicer
and/or other host nucleases. Further studies are required to fully
understand themolecular interplay of sfRNA, and the RNA struc-
tures within the molecule, with RNAi and the relative importance
of the interaction for flavivirus transmission in vivo.
Our finding that sfRNA is very important in mosquito infec-
tion is in linewith recent research that studied themutation rate of
flavivirus 3= UTR RNA sequences in the insect host. It was dem-
onstrated for DENV-2 that the XRN1/Pacman-resistant RNA
structures SL-I and SL-II (equivalent to SL-II and SL-IV, respec-
tively, forWNV) evolve differently depending on the origin of the
host cell. In mosquito cells, SL-II incorporated mutations very
rapidly compared to the upstream SL-I, which was conserved in
mosquito cells but mutated more frequently during infection of
mammalian cells (34). This suggests that the XRN1/Pacman-re-
sistant SL-I is under strong selective pressure to be maintained in
the insect host, most likely to safeguard production of sfRNA1.
Consistent with this notion, it was recently reported that sfRNA
plays a role in flavivirus transmission during a DENV epidemic. A
DENV clade from Puerto Rico was outcompeted by a new clade
that produced higher sfRNA/vgRNA ratios, indicating that sfRNA
TABLE 3 Three replicate blood feeding experiments demonstrate that deficiency in sfRNA1 and sfRNA2 results in decreased WNV infection and
transmission rates in C. pipiensa
Virus Replicate n Positive bodies (no.) Positive saliva (no.) Infection (%) Transmission (%) Dissemination (%)
WNVIC 1 23 8 7 35 30 88
2 28 3 2 11 7 67
3 22 1 1 5 5 100
Total 73 12 10 16 14 83
WNVSF1 2 1 18 0 0 0 0 0
2 36 2 2 6 6 100
3 29 0 0 0 0 0
Total 83 2 2 2 2 100
a Shown are infection, transmission, and dissemination rates of orally infected C. pipiens mosquitoes with either WNVIC or WNVSF12. In addition, the sample size (n) as the
number of engorged females after a blood meal and absolute numbers of positive bodies and saliva samples are shown for each replicate.
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production correlates with increased epidemiological fitness (32).
Our results support and extend this hypothesis by demonstrating
for the first time that sfRNA is required for successful flavivirus
transmission by mosquitoes.
In conclusion, we have shown that sfRNA is a key driver to
overcome the mosquito midgut infection barrier to establish a
transmissible infection.Moreover, we provide novel evidence that
sfRNA is processed by the RNAimachinery in vivo in mosquitoes.
Our results provide the first biological explanation for the highly
conserved nature of sfRNA among all flaviviruses, foremost those
that replicate in mosquitoes, which may offer novel targets to in-
terfere with the complex flavivirus transmission cycle in nature.
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